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Phytohemagglutinin (PHA),  an  extract  from  the  kidney bean  Phaseolus 
vulgaris in which the active principle is a protein molecule with a high affinity 
for polysaccharides, has a marked mitogenic effect upon peripheral lymphocytes 
in vitro  (1,  2).  Most studies of this phenomenon have concerned themselves 
with the  action of PHA upon immune competent lymphocytes. It has been 
shown that such cells exposed to PHA undergo blastoid transformation, enter 
mitosis, begin synthesizing protein, and in some cases manifest an anamnestic 
response (3-5).  Recently, however, several investigations have considered the 
effects of PHA on the marrow lymphocyte and on hemopoiesis. Humble  (6) 
postulated that PHA might result in marrow stimulation in cases of aplastic 
anemia by causing proliferation and/or transformation of the marrow lympho- 
cyte, which is believed by some workers to represent the stem cell  (7, 8). He 
administered PHA to six patients with symptomatic aplastic anemia and re- 
ported evidence of marrow stimulation in all cases, Other workers have reported 
results suggesting that  PHA  provides  significant but  temporary stimulation 
of hemopoiesis in cases of drug-induced marrow failure, but that it is ineffective 
in cases of idiopathic aplastic anemia (9-11).  In an experiment involving in 
vitro culture of the aplastic anemic patient's peripheral leukocytes with PHA, 
followed by injection of the stimulated cells  directly back into the patient's 
marrow spaces, Astaldi et al.  (12)  found only equivocal indications of hemo- 
poietic stimulation. 
Papac (13) working with PHA in vivo in small rodents, looked for radiopro- 
tective and Inyeloproliferative effects after lethal doses of irradiation, but found 
no conclusive evidence for such effects. We have previously reported that lymph 
nodes but not thymus of PHA-treated mice undergo a slight increase in their 
low content of spleen colony-forming units (14).  This paper seeks to explore 
further the action of PHA upon hemopoietic precursor cells. 
* This investigation was supported by Public Health Service Grants CA 03367, T1 CA 
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Materials  and Methods 
The animals used and methods for administering X-irradiation,  producing endogenous 
colonies, collecting and injecting bone marrow cells, harvesting and counting spleen colonies, 
and identifying the types of colonies, have been described in previous publications (15, 16). 
Retransplantation  of colonies was performed by dissecting out individual colonies  from the 
fresh spleen with sharp pointed scissors and small pointed forceps. The colony was then cut 
in half; one piece was placed directly into 0.2 ml of Eagle's minimum essential medium (MEM) 
without serum, and the other was imprinted lightly, cut surface down, three times on a clean 
glass slide and then placed into the MEM. The cells were expressed from the colony halves by 
gentle pressure from a smooth-tipped glass rod, and the bits of stroma remaining were re- 
moved. In some cases cell counts were performed on the suspensions at this point,  in the 
manner described previously (15), to determine the number of viable nucleated cells. The cell 
suspension was diluted to 0.5 ml with MEM, taken up in a tuberculin syringe, and injected 
into a single recipient mouse via a lateral tail vein. The imprints were air dried, fixed for 3 min 
in absolute methanol, and stained by the May-Griinwald-Giemsa technique (17). 
Phytohemagglutinin (PHA) was generally administered by the intraperitoneal route. Rigas 
and Osgood (18) reported that the purified protein fraction of PHA retained all of the mito- 
genic activity possessed by the mucoprotein substance and was 50 times more potent.  For 
this reason the more refined PHA-P  1 was used rather  than the mucoprotein PHA-M  ~. The 
dose used was 20/zg per g of body weight of the protein PHA dissolved in isotonic saline and 
administered in a volume of 0.5 ml. This dose was comparable to the amounts used by Mac- 
Kinney (19) for the study of human lymphocytes in vitro, but is below the levels found toxic 
in vivo by Norins and Marshall (20). Mekori et al. (21) reported using 0.3 ml of PHA-M per 
mouse intravenously, which when prepared in the customary fashion is approximately equal 
in potency to 10/zg of PHA-P per g of body weight. 
RESULTS 
Effect of PttA Treatment of the Bone Marrow Donor on the Number and Types 
of Spleen Colonies Formed.--Two groups of mice were exposed to 850 R  whole- 
body X-irradiation. One group was injected with femoral marrow cells (4 X  104, 
8  X  104, or 12 X  10  ~ viable nucleated isogeneic ceils) from a pool of three nor- 
mal donors and the other group was injected with the same number of pooled 
marrow cells from three donors that had received daily injections of PHA for 3 
days prior to sacrifice. All recipient mice were sacrificed 8 days after marrow in- 
jection, the spleens removed and the colonies counted. There was a  consistent 
but slight decrease  (not quite statistically significant) in the total number of 
colonies found. The proportions of the various cell types of colonies were not 
significantly changed (Table I). 
Effect of PHA  Treatment of the Marrow Recipient  on Developing Spleen Colo- 
nies.--Two groups of mice were exposed to 850 R whole-body X-irradiation and 
injected with 4  X  1@ cell aliquots of the same marrow suspension from a single 
isogeneic donor.  One group was not treated further, while the other received 
daily intraperitoneal injections of PHA. All mice were sacrificed 8  days after 
marrow injection, the spleens were weighed, and sections were made for colony 
1 Difco Bacto-Phytohemagglutinin P, Code 3110, Difco Laboratories, Detroit, Mich. 
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counting and typing. A third group of animals was irradiated but not injected, 
to  determine  the  postirradiation weight  of  spleens without  colonies.  In  the 
PHA-treated mice there were approximately the same total number of colonies, 
TABLE I 
Number and Type of 8-Day Spleen Colonies in 850 R-Irradiated Mice Receiving Marrow 
from Normal or from PItA-Treated Donors 
Experi- 
ment 
Marrow 
donor 
pretreatment 
None 
PHA 
None 
PHA 
None 
PHA 
No. of 
Cell dose  mice 
4  X  104 
8  X  10  4 
12  X  10  4 
g¢ 
16 
12 
18 
18 
10 
12 
Per cent of colony types 
Ery, 
55 
59 
53 
49 
57 
54 
Neutr. 
15 
22 
19 
24 
14 
17 
Meg.  Undiff. 
8  4 
4  7 
8  6 
10  4 
10  4 
7  5 
Mixed 
18 
8 
14 
13 
15 
17 
Mean total 
colonies  per  spleen' 
5.8  4- 0.64 
3.6  4- 0.53 
7.9  4-  0.66 
5.8  4-  0.80 
15.0  4-  1.29 
11.8  4-  1.02 
In this and other tables, Ery., erythroid; Neutr.,  neutrophilic; Meg., megakaryocytic. 
*  :::t:: SE 
0.1  >  p  >  0.05 between groups in any experiment. 
TABLE  II 
Number, Type, and Weight of 8-Day Spleen Colonies in Irradiated Recipients of Normal 
Marrow, Given Daily Injections of PItA until Sacrifice 
Group 
850 R 
850 R and 
B.M.~ 
850 R  and 
B.M. and 
PHA 
No, 
3se  of 
nic~ 
12 
10  18 
18 
Mean total 
colonies 
per  spleen* 
B 
6.9  4-  0.7 
6.8  4-  0.8 
Per cent of colony 
types 
c  5111 
2(  1 14: 
I 
Mean  spleen 
weight* 
mg 
19.7  4-  1.44 
35.9  4-  2.53 
26.3  -4-  1.2C 
M  I Mean  earl i  we'  "t 
re"  ht  •  ~n  • ~  [  mdtvtd-  all 
olonles[  tml. 
colonies 
16.2  t 2.3 
6.6  0.97 
I 
I 
* --~--  SE 
:~  B.M., bone marrow calls. 
but there was a  significantly greater proportion of mixed colonies, more mega- 
karyocytes, and a reduction of the proportion of erythroid, of neutrophilic, and 
of undifferentiated colonies (Table II). Histologically, the appearance of the de- 
veloping colonies was quite similar to that of colonies in untreated hosts except 822  HEMOPOIETIC  SPLEEN  COLONY  STUDIES.  IV 
in two regards. In addition to the normal spectrum of cell types usually found in 
spleen colonies there was an unusually high proportion of large, undifferentiated 
ceils, many of which had a blastoid appearance (Fig. 1). These cells resembled 
in  general  appearance  the  transformed ceils found in  cultures of peripheral 
lymphocytes cultured with PHA. The other unusual feature was the finding of 
hemopoietic ceils,  nearly  always  of mixed  types,  in  a  peculiar,  sharply  de- 
lineated distribution (Fig. 2). The appearance suggests that sinusoidal passages 
are packed with proliferating or emigrating hemopoietic ceils. It may be signifi- 
cant that the bone marrow sinusoids are normally rich in small lymphocytes, 
TABLE III 
Mean Cell Counts of the Five Largest 8-Day Colonies of Each Spleen in Irradiated, Marrow- 
Injected Mice Given Daily Injections of PHA until Sacrifice 
Group 
850 R and 
B.M.:~ 
850 R and 
B.M. and 
PHA 
Per cent of colony types 
Mixed  i°1  Gr u1°id 
of  Erythroid  8 
mice "~- 
"d'~  Mean No.  1"8"~ 
52  of cells  ] d'~ 
Mean No. 
of cells 
3.2 X  10  5 
2.9 X  10  5 
~u 
12 
23 
Mean No. of 
ceils 
Mean total 
colonies 
(gross)* 
17.1  X  10  5  9.3  -4-  2.4 
5.6 X  10  5  8.7.-4-  1.1 
Graad mean 
No. of cells 
for five 
largest 
colonies 
8.6 X  10  5 
4.9 X 10  5 
* ::ESE 
:~ B.M.,  bone marrow cells. 
i.e.,  the  "lymphocyte loading"  of  Yoffey (7).  In  general  the  colonies  were 
smaller (Table II). The size of the colonies was determined in two ways: 
Mean colony weight was estimated by determining the mean weight of spleens 
without colonies and subtracting this from the mean weight of spleens contain- 
ing colonies. The difference was then divided by the mean mtmber of colonies 
per spleen to arrive at the mean single colony weight. The colonies developing 
under the influence of PHA weighed on the average only half as much as normal 
colonies (Table II). 
Mean cell number per colony:  In this experiment the same treatment groups 
were used as for the experiment above, but the colonies were counted grossly 
in the fresh spleen, and the five largest colonies dissected out, imprinted for 
identification,  and  suspended  for  cell  counts.  Again  there  was  virtually  no 
difference in the total number of colonies and there were relatively more mixed 
colonies  (Table  III).  No  megakaryocytic or  undifferentiated  colonies  were 
found, but we have shown that none are to be expected by this method for they J.  L.  CURRY  AND  J.  J'.  TRENTIN  823 
are too small to be grossly visible and dissectable (15). The cell counts verified 
the impression that the colonies developing under the influence of PHA were 
smaller. This was particularly true  of the mixed colony type. Either PHA re- 
duced the rate of growth of spleen colonies, or, perhaps more likely, increased 
the rate of emigration of cells out of the colonies and into the sinusoids. 
Effect of PttA on the Colony-Forming Unit (CFU) Content of Spleen Colonies. 
--Two groups of animals were irradiated with 850 R. Each animal was injected 
with a suspension of all the cells expressed from a single colony, one group re- 
ceiving normal  10-day colonies while the other group received colonies which 
developed under the influence of PHA for 10 days as in the experiments above. 
10 days after injection the recipients were sacrificed and the spleens prepared 
TABLE  IV 
Mean CFU Content of, and Cell Types of lO-Day Colonies Formed by Retransplantation of 
lO-Day Colonies Arising in PHA-Treated and Untreated Hosts 
Source of transfused  cells 
10-day normal colonies 
10-day  colonies arising  in 
PHA-treated hosts 
No. Of 
colonies 
25 
22 
Mean No. of 
secondary colonies 
per injected  colony* 
12.8  4-  3.1 
4.5  +  1.3~t 
Per cent of 10-dsy secondary  colony types 
Ery__ Gran__  Meg--  Undiff__  1~ i~ ed 
51  I  20  I  8  I  5  1  16 
56  17  10  3  14 
In this table, Gram, granuloid. 
*  :=~= sE 
p  <  0.02. 
for histological study. The results are shown in Table IV. The PHA-treated 
colonies had significantly fewer CFU's,  but the  spectrum of colonies formed 
upon retransplantation was almost identical with that of normal colonies. 
Effect of PHA  on Endogenous Colonies.--Since  PHA  tended to reduce the 
number of CFU's in the marrow, it was of interest to study the effect of this 
agent on the formation and development of endogenous colonies. 
Two groups of animals were irradiated with 770 R, and one group was given 
daily injections of PHA  until  sacrifice.  The  spleens  were  harvested  9  days 
postirradiation and prepared for histological study. The results are shown in 
Table V. At this dose of irradiation PHA significantly increased the number of 
endogenous colonies formed, but there were too few colonies in these experi- 
ments to determine whether there was any effect of PHA on the colony types. 
However, pooled data from these and several other experiments involving PHA 
and endogenous colonies revealed considerable differences in  the proportions 
of the various colony types found. In particular,  as in the case of exogenous 
marrow colonies, there was an increase in mixed colonies at the expense of the 824  HEMOPOIETIC SPLEEN COLONY STUDIES. IV 
other types (Table VI). When similar experiments were done giving PHA injec- 
tions  for  3  days prior  to  irradiation,  no  significant  effect  on  the  number  of 
endogenous colonies was noted. It was concluded that PHA administered after 
irradiation  increased  the  number  of  endogenous  colonies  and  increased  the 
proportion of mixed endogenous colonies. 
TABLE V 
Number and Type of Endogenous Colonies Formed in Mice Receiving 770 R and Daily 
Injections of PHA 
Experi-  Group  merit 
1  770 R only 
770 R and PHA 
2  770 R only 
770 R and PHA 
No. of  mice 
12 
10 
12 
12 
Mean total colonies  per spleen* 
0.09  4- 0.009 
3.3  4- 0.87~t 
0.17  -4-  0.02 
3.5  -4-  0.93~ 
No. of colonies  of each type 
Ery.  Neutr. Meg. Undiff. 
10  3  1  -- 
1  --- 
9  5  3  -- 
Mixed 
19 
1 
24 
* -I- SE 
:~ p  <  0.Ol. 
TABLE VI 
Distribution of the Various Cell Types of Endogenous Colonies in Irradiated Untreated 
and Irradiated PHA-Treated  Mice* 
Treatment 
Irradiation only 
Irradiation and PHA 
Range of  i irradiation  [  dose 
] ...... 
R 
500-700 
770-850 
Range  of  colon~  age 
days 
8-10 
8-10 
J 
~.  No. of 
mice colonies 
87  367 
51  89~ 
Per cent of endogenous  colony types 
....  Ery.~  Neutr.128 Meg.3.52 Undiff. __Mixed6518.5 
* Pooled data from several experiments. 
:~ The smaller number of colonies per spleen of PHA-treated animals is the result of higher 
dose of irradiation. At comparable irradiation doses, PHA-treated animals had more colonies 
per spleen (see Table V). 
Effect  of  PllA  on  Survival  after  Whole-Body  Irradiation.--The  increased 
number  of endogenous  spleen colonies found  after PHA  treatment  raised the 
possibility of more rapid hematologic recovery after irradiation and subsequent 
manifestation as improved survival. Paired groups of animals were irradiated 
at 600, 700, 800, and 900 R. The mice in one group of each pair were given daily 
injections of PHA for 21  days  postirradiation.  The PHA-treated mice had  a 
significantly improved survival at 600 and 700 R, as determined by the Kolmo- 
gorov-Smirnov test (22) for the difference between two cumulative percentages J.  L.  CURRY  AND  J.  J.  TRENTIN  825 
(Text-Fig.  1).  At higher doses of irradiation no protective effect was noted. 
Similar experiments were performed using pretreatment of the mice with injec- 
tions of PHA on the 3 days prior to irradiation, but no significant difference in 
survival was noted at any of the four irradiation dose levels. 
DISCUSSION 
The results indicate that PHA exerts significant effects upon hematopoietic 
tissues in vivo. These effects are  apparently multiple and complex, and not 
simple  of  interpretation.  Apparently  opposing  effects were  obtained  in  the 
endogenous irradiation recovery experiments as compared to the bone marrow 
transplantation experiments. In the former, PHA administered after irradiation 
(but not before irradiation) stimulated endogenous hemopoietic spleen colony 
formation, and enhanced postirradiation recovery and survival. In the trans- 
planted marrow systems, PHA treatment of the donor, if anything, reduced 
the number of CFU, whereas PHA treatment of the recipient resulted in smaller 
more  differentiated colonies.  Whether any of these  effects are  related  to  or 
secondary to previously reported effects of PHA is not clear. The previously 
reported biological effects of PHA include the following: 
Hemagglutinating activity: this leaves the  leukocytes free  in  suspension; 
first used for a  rapid and efficient separation of leukocytes from blood by Li 
and Osgood (23). 
Mitogenic activity in vitro:  peripheral leukocytes (later shown to be lympho- 
cytes) incubated in vitro with PHA were shown to transform into blasts and 
begin dividing (1); PHA provided mitotic stimulation to all of the lines of tissue 
culture cells to which it was added (24). 
Leukoagglutinating activity: Hirschhorn et al. (4) showed that PHA caused 
aggregation of lymphocytes prior to transformation and mitosis. 
Stimulation of an immune response:  lymphocytes after transformation by 
PHA have  been  shown to produce  -r-globulin  (4)  and  react  with a  specific 
anamnestic response (5). 
Radioprotective activity: Schrek and Stefani (25) demonstrated that stimu- 
lation by PHA conferred a remarkable radioresistance on lymphocytes in vitro, 
but Papac (13) could not obtain a significantly improved survival of irradiated 
mice when PHA was administered in one dose immediately after irradiation. 
Myeloproliferative activity: Humble (6) found evidence of marrow stimula- 
tion in all of six aplastic anemia patients given PHA, and Israel et al. (26) found 
that PHA increased the hematologic tolerance of patients to massive cancer 
chemotherapy. However, Papac (13) could find no significant effect of PHA on 
the cell count or morphology of rodent marrow after irradiation. 
Toxicity: several workers (13, 20, 27) have investigated the toxicity of PHA 
in mice. Respiratory distress, paresis, and sudden death are most commonly 
reported,  especially when PHA was administered intravenously. Arthus reac- 826  HEMOPOIETIC  SPLEEN  COLONY  STUDIES.  IV 
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tion's and anaphylaxis were found with repeated injections of PHA in guinea 
pigs. 
An important consideration is whether several of the above are manifesta- 
tions of the same effect. The hemagglutinating effect, although once believed 
inseparable from the mitogenic effect (28),  has been selectively removed both 
by drastic chemical procedures  (29)  and by repeated absorption by red cells 
(30), leaving only the mitogenic activity. However, many of the other effects of 
PHA may be explained on the basis of one or the other of these two separable 
properties. Hirschhorn et al. (4) concluded that leukoagglutination, transforma- 
tion to blasts, mitosis, and ~r-globulin synthesis were different stages in a single 
response of lymphocytes to PHA. 
The toxicity of PHA might well be explained by intravascular hemagglutina- 
tion and possibly pulmonary emboli. In mice receiving doses of PHA over long 
periods anaphylaxis might be considered as a mode of toxicity; but in the ex- 
perience of this laboratory adverse reactions have occurred only acutely, after 
the first intravenous dose of PHA, and a  phenomenon more immediate than 
allergy must be postulated. 
For the purposes at hand, the most interesting effect is that of transformation 
of cells  in vitro. Most work along these lines has been done with peripheral 
lymphocytes, which are the only cells in peripheral blood that respond to PHA. 
This phenomenon might be due either to the possibility that PHA has a spe- 
cific effect on lymphocytes or to the fact that of all the cells in the blood, only 
the lymphocytes are capable of mitosis. PHA might be a nonspecific stimulant 
for mitosis. Recent studies have shown PHA to be a stimulant for growth in 
several lines of cells in tissue culture (24). 
At least one action of PHA on the cell membrane is known: agglutination of 
like cells. As Hirschhorn has suggested, this in itself is necessary and sufficient 
to trigger new metabolic activities in some cell types. That cell-to-cell contact 
has some role in regulating cell division is apparent not only from in vitro stud- 
ies with lymphocytes but also from the well-known tissue Culture phenomenon 
of "contact inhibition." 
L 
The rationale for Humble's use of PHA in aplastic anem~:i(6) rested on the 
possibility that the  PHA  transformation of lymphocytes,:'~hich"~¢-  are  usually 
present  in  that  disease,  might  include  transformation  to  stem  cells  which 
could repopulate the marrow. The results of work along this line, although not 
providing unequivocal evidence, are quite suggestive of some kind of myelo- 
proliferative effect which cannot be explained on the basis of hemagglutination 
or lymphocyte transformation to immune-active cells. Astaldi et al. (12) found 
signs of increased marrow cellularity and function when they exposed a patient's 
lymphocytes to PHA in vitro and then reinjected them into the marrow cavity, 
suggesting that PHA can transform lymphoid cells into myeloid precursors. 
The increased number of endogenous colonies after a given dose of irradiation, 828  HEMOPOIETIC SPLEEN COLONY STUDIES. IV 
the formation of spleen colonies by lymph node cells,  and the improvement in 
postirradiation survival found with injections of PHA or lymphoid cells from 
PHA-treated donors can all be explained by the hypothesis that  PHA may 
transform a  precursor cell (which may appear morphologically as a  lympho- 
cyte) into a functionally myeloid CFU. On the other hand, the decreased CFU 
content of the bone marrow and increased CFU content of the lymphoid organs 
of PHA-treated mice might in fact represent PHA-induced migration of CFU 
from marrow to lymphoid organs, and possibly elsewhere. Indeed Micklem (31) 
has reported an increase in the spleen colony forming units circulating in the 
blood of mice 72 hr after intravenous injection of 0.3 ml of PHA, and a small in- 
crease in the CFU content in the lymph nodes. 
The disparity in the results between testing the effects of PHA in the en- 
dogenous system and in the transplantation system presents a  problem in in- 
terpretation. Porteous and Lajtha (32) have cautioned against comparison of 
hemopoietic regeneration studies  in  the  two  systems,  pointing  out  that  the 
transplantation system, compared to endogenous repopulation, is nonphysio- 
logic, involves the trauma of manipulation,  and often fails to transplant  the 
stem  cells which  are manifest in the  endogenous system. A  consideration of 
their criticisms has led us to speculate that perhaps the stem cell or CFU exists 
in two forms-a small lymphocytoid form which is transplantable,  and a  large, 
undifferentiated hemohistioblast which  (perhaps because of its size, fragility 
and/or attachment to the reticulum) is not amenable to transplantation in a 
cell suspension given intravenously. In order to reach the spleen or bone marrow, 
intravenously transplanted stem cells must first traverse the pulmonary vascu- 
lar network. If the effect of PHA upon the CFU is indeed to stimulate pro- 
liferation involving a  blastoid  transformation  (in  a  fashion analogous  to its 
effect upon lymphocytes in vitro), the observation of blastoid cells in the PHA- 
influenced spleen colonies and the results of these experiments are understand- 
able, i.e., PHA-transformed stem cells may not be detectable by transplantation 
but readily detectable in an endogenous system (increase in endogenous colonies 
or improved survival postirradiation). 
Further experiments in this area should include studies on the in vitro effects 
of PHA on bone marrow and on the CFU content of lymphocytes from various 
sources transformed in vitro by PHA. 
SUMMARY 
The effects of phytohemagglutinin (PHA) were studied in irradiated mice to 
see if a  definite myeloproliferative effect could be demonstrated in vivo. The 
data obtained suggested the following conclusions. 
PHA  treatment  of the  bone marrow  donor only,  causes  a  consistent  but J.  L.  CURRY  AND  J.  J.  TRENTIN  829 
slight reduction in transplantable  spleen colony-forming unit  (CFU)  content 
of the bone marrow 24 hr after the last PHA injection, but no change was 
found in the proportion of the various colony types. 
PHA treatment of the irradiated recipient of normal bone marrow causes no 
change in the number of spleen colonies. However, 8-day colonies are only about 
half normal size, are much more likely to be of mixed cell types, contain many 
large undifferentiated blastoid cells, but fewer transplantable CFU. The spleen 
sinusoids are packed with hemopoietic cells. 
Spleen colonies developing in hosts receiving daily injections of PHA show, 
in addition to the usual spectrum of cell types, a  high proportion of unusual 
blastoid cells resembling the PHA transformed peripheral lymphocytes seen in 
vitro. The function of these cells is not known, but they may represent  aug- 
mented proliferation and/or transformation of stem cells. 
PHA  administered  after irradiation  significantly increased  the  number  of 
endogenous spleen colonies, and, at certain doses of irradiation, improved post- 
irradiation survival. 
PHA  administered before irradiation  had  no effect on  the  number  of en- 
dogenous spleen colonies formed, or on postirradiation survival. 
On the basis of these and other data, possible modes of action of PHA are 
discussed. 
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EXPLANATION  OF PLATES 
PLATE 61 
FIG.  1.  Large,  undifferentiated, blastoid cells  appearing in a  spleen colony in a 
(C5~ X  M)F1 mouse which received 850 R  whole-body irradiation, 8  ×  104 viable 
isogeneic marrow cells, and daily injections of 0.4 rag PHA-P until sacrifice  10 days 
postirradiation. Such cells are much more common in colonies arising in PHA-treated 
hosts, and they resemble in many ways the PHA-transformed lymphocytes seen in 
tissue culture. Hematoxylin and eosin.  X  1400. THE  JOURNAL OF  EXPERIMENTAL  MEDICINE  VOL. 126  PLATE 61 
(Curry and Trentin: Hemopoietic spleen colony studies. IV) PLATE 62 
FIG. 2.  Intrasinusoidal  mixed hemopoietic cells occurring in the spleen of a (C57 X 
Af)F1 mouse which had  received  850  R  whole-body irradiation, 8  X  104  isogeneic 
marrow  cells  and daily injections of  PHA,  until sacrifice  10  days postirradiation. 
Neither the homogeneous mixture of different cell types nor the peculiar intraluminal 
"packing" of hemopoiesis  have been noted in the spleens of colony-bearing hosts not 
treated with PHA. In the marrow, however,  lymphocytes in unusually high concen- 
trations are  characteristically found within the  sinusoids. Hematoxylin and  eosin. 
X 306. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 126  P~ATE 62 
(Curry and Trentin: Hemopoietic spleen colony studies. IV) 